Episode 11

The Immunotherapy Series, Part Three: Policy and the FDA

Out of Patients with Matthew Zachary · Matthew Zachary

April 16, 202021m 7s

Audio is streamed directly from the publisher (pdcn.co) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Immunotherapy and Policy. How can the FDA evolve to help advance and support novel approaches to medicine? How does the field of immune-driven diagnostics serve as a case in point for the need for evolution in existing regulatory frameworks?

Special guests:

Meghan Gutierrez

Chief Executive Officer

Lymphoma Research Foundation

Leo David Wang, M.D., Ph.D.

Assistant Professor, Department of Immuno-Oncology

Assistant Professor, Department of Pediatrics

City Of Hope

This series is brought to you ad-free by Adaptive Biotechnologies

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Topics

digital healthpatient centricitypatient outcomesdrug pricingobamacareHealthCarehealthwell-beingWellnessAnxietystressMental HealthleadershipleadermotivationalMotivationInspirationalinspiringauthenticityStorytellingStorytellersupportCommunitychronic illnessrare diseasechronic diseasesurvivorCancercaregivingcaregiverpatient storiespatient engagementengagementpatient educationEducationpatient empowermentEmpowermentpatient advocacyadvocacyadvocateoffscriptoffscripstupid cancermatthew zacharyMatthew Zacharyreal world evidenceaudio researchpatient insightsvaxonout of patienceoffscrip mediaCOVID-19COVIDelura nanosjen horonjeffsavvy coopvaccinesvaccinationspatient experienceactivismsocial mediainfluenceinfluencersinfluencerOut of Patientspodcastpodcasting

← All episodes of Out of Patients with Matthew Zachary